Behar Gregory 4
4 · Seres Therapeutics, Inc. · Filed Jun 23, 2023
Insider Transaction Report
Form 4
Behar Gregory
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+35,000→ 35,000 totalExercise: $5.46Exp: 2033-06-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.